1. Home
  2. MYFW vs AARD Comparison

MYFW vs AARD Comparison

Compare MYFW & AARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MYFW

First Western Financial Inc.

HOLD

Current Price

$26.08

Market Cap

220.8M

Sector

Finance

ML Signal

HOLD

Logo Aardvark Therapeutics Inc.

AARD

Aardvark Therapeutics Inc.

HOLD

Current Price

$14.43

Market Cap

231.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYFW
AARD
Founded
2002
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
220.8M
231.9M
IPO Year
2018
2025

Fundamental Metrics

Financial Performance
Metric
MYFW
AARD
Price
$26.08
$14.43
Analyst Decision
Buy
Strong Buy
Analyst Count
2
9
Target Price
$24.25
$30.63
AVG Volume (30 Days)
26.2K
211.9K
Earning Date
01-22-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
391.62
N/A
EPS
1.28
N/A
Revenue
$95,514,000.00
N/A
Revenue This Year
$15.96
N/A
Revenue Next Year
$13.77
N/A
P/E Ratio
$20.10
N/A
Revenue Growth
19.92
N/A
52 Week Low
$17.10
$4.88
52 Week High
$26.28
$19.58

Technical Indicators

Market Signals
Indicator
MYFW
AARD
Relative Strength Index (RSI) 74.03 64.16
Support Level $23.72 $12.54
Resistance Level $26.28 $16.00
Average True Range (ATR) 0.56 1.01
MACD 0.21 0.58
Stochastic Oscillator 89.95 76.10

Price Performance

Historical Comparison
MYFW
AARD

About MYFW First Western Financial Inc.

First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.

About AARD Aardvark Therapeutics Inc.

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.

Share on Social Networks: